04Jun
Cannabis-Derived Ingredients in FDA-Regulated Products: More Questions than Answers at FDA’s May 2019 Public Hearing
As most folks with any interest in the burgeoning cannabidiol (CBD) industry likely know, on May 31, 2019, the Food and Drug Administration held a public hearing “to obtain scientific data and information about the safety, manufacturing, product...
By:
Mintz - Consumer Product Safety Viewpoints
Related
With the NBA season set to begin this month, so many eagerly anticipated storylines are being discus...
Read More >
MTA Royalty Corp. v. Compania Minera Pangea, S.A. DE C.V., C.A. No. N19C-11-228 AML CCLD (Del. Supe...
Read More >
Northrop Grumman has agreed to pay $12,375,000 to settle a class action brought under the Employee R...
Read More >
On July 22, 2019, the Ninth Circuit withdrew its recent decision in Vazquez v. Jan-Pro Franchising I...
Read More >
A New York trial court recently upheld the enforceability of a no-damages-for-delay clause in a cont...
Read More >
Coronavirus: a bacteria-ridden beer bottle with a lime? No. Pandemic? Not quite. A serious health co...
Read More >